- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Availability of Drug Information on Bioequivalence of Generic Products -Findings of Graduate Interns at a University Pharmacy-
-
- ONDA Mitsuko
- Osaka University of Pharmaceutical Sciences
-
- KANEMATSU Miwa
- Osaka University of Pharmaceutical Sciences
-
- KITAMURA Tomoko
- Osaka University of Pharmaceutical Sciences
-
- SAKAI Takahiro
- Osaka University of Pharmaceutical Sciences
-
- SAKAGAMI Kumiko
- Osaka University of Pharmaceutical Sciences
-
- TANAKA Keiko
- Osaka University of Pharmaceutical Sciences
-
- HAMAHATA Yukimi
- Osaka University of Pharmaceutical Sciences
-
- HIROOKA Teruko
- Osaka University of Pharmaceutical Sciences
-
- FUJII Kiwako
- Osaka University of Pharmaceutical Sciences
-
- MATSUDA Masafumi
- Osaka University of Pharmaceutical Sciences
-
- MIKI Haruna
- Osaka University of Pharmaceutical Sciences
-
- MASHIMO Hirotaka
- Osaka University of Pharmaceutical Sciences Pharmacy
-
- HADA Rie
- Osaka University of Pharmaceutical Sciences Osaka University of Pharmaceutical Sciences Pharmacy
-
- ARAKAWA Yukio
- Osaka University of Pharmaceutical Sciences
Bibliographic Information
- Other Title
-
- 後発医薬品の生物学的同等性に関する情報提供のあり方 ―大学院生の附属薬局研修からの考察―
- コウハツ イヤクヒン ノ セイブツガクテキ ドウトウセイ ニ カンスル ジョウホウ テイキョウ ノ アリカタ ダイガクインセイ ノ フゾク ヤッキョク ケンシュウ カラノ コウサツ
Search this article
Description
Access to drug information (DI) needed to evaluate generic product bioequivalence was studied to identify problems with the current status of DI availability and encourage proper use of DI. Ten items were chosen from among the stock of branded products at the University Pharmacy, and five corresponding generics were selected for each item. Conditions of access to information on pharmacokinetic tests and dissolution tests were rated and the assigned ratings compared. In the case of pharmacokinetic parameters obtainable from makers of generic drugs, we also performed Welch's t-test to compare the difference between values reported for branded and generic products. From the standpoint of individual tests, the pharmacokinetic tests yielded higher scores on the whole than did the dissolution tests, and low scores were obtained for the half-life of blood drug concentration (T1/2). We observed a tendency for the adequacy of information to depend more upon the drug item itself than upon the nature of the test. The percentage of tests allowing for comparison with branded products varied from 0%-75% (average 49%). Parameter by parameter, the range of variation was from 35% of Tmax to 63% of Cmax. Factors precluding comparison included insufficient data on branded products, mismatch in assayed chemical species between branded and generic, mismatch between final sampling time in AUCt measurement, dosage inconsistency, and insufficient data on generic products. DI should be provided in a manner that facilitates comparison of information supplied by generic drug makers with data released by makers of branded products.<br>
Journal
-
- YAKUGAKU ZASSHI
-
YAKUGAKU ZASSHI 127 (7), 1159-1166, 2007
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390282681104713984
-
- NII Article ID
- 110006318165
-
- NII Book ID
- AN00284903
-
- COI
- 1:STN:280:DC%2BD2szos1equg%3D%3D
-
- ISSN
- 13475231
- 00316903
-
- NDL BIB ID
- 8882207
-
- PubMed
- 17603276
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed